Helping patients reduce reliance on sleep medications in primary care
Official title: Enhancing Hypnotic Medication Discontinuation in Primary Care Through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
Run by National Jewish Health · NCT06435520 · Data updated 2026-11-12
This study is testing a new way to help people with insomnia safely cut back on sleep medications by using a combination of online therapy and a plan to reduce their medication, compared to regular care.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 430 (estimated) |
| Sponsor | National Jewish Health Academic / other |
| Locations | 1 site (Denver, Colorado) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2029 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT06435520 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with a history of extended use of hypnotic medications for insomnia who wish to decrease or eliminate their use.
✕Probably not a fit
Patients with severe psychiatric disorders, significant cognitive impairment, or those currently using hypnotics for other medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to address the challenge of hypnotic medication dependence among insomnia sufferers in primary care settings. It will conduct a large randomized trial comparing a combined digital cognitive behavioral therapy (dCBTI) and structured medication tapering intervention against standard care. The goal is to validate a cost-effective approach that helps patients safely reduce or discontinue their use of hypnotics while managing their insomnia effectively. By bridging the gap between research and clinical practice, this study seeks to improve patient outcomes in managing insomnia.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the reliance on hypnotic medications and improve sleep quality for patients with insomnia.
How similar studies have gone: Previous studies have shown promise in using cognitive behavioral therapy and medication tapering for insomnia, indicating that this approach could be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * a history of extended (\> 6 consecutive months) and frequent (\>5 nights/week on average) use of benzodiazepine (BZD) or non-BZD hypnotic medications; * a desire to decrease/eliminate hypnotic use; * a history of insomnia that meets DSM-560 criteria for insomnia disorder; and * willingness to provide written informed consent to participate. Exclusion Criteria: * a lifetime diagnosis of any psychotic disorder, suicide attempts, or bipolar disorder; * presence of an unstable, untreated, or terminal major medical or psychiatric disorder; * alcohol or drug abuse within the past year; * current use of a BZD for another disorder in addition to insomnia (e.g., seizure disorder, restless leg syndrome, anxiety disorder); * pregnancy; * significant cognitive impairment as suggested by a score of ≤ 24 on the Folstein Mini-Mental State Examination (MMSE); * current use of medications known to cause insomnia (e.g., high dose corticosteroids); * untreated comorbid sleep disorders; * use of a sedating antidepressant or antipsychotic medication solely for sleep; and * consuming \>2 alcoholic beverages/day ≥5 times/week or any use of marijuana ≥5 times/week.
Where it's running
-
National Jewish Health
Denver, Colorado, United States Recruiting
Study contacts
- Study coordinator: RJ Johnson, MA
- Email: chp@njhealth.org
- Phone: 303-398-1058
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.